Sebastian Himbert and Maikel Rheinstadter are part of an interdisciplinary team at McMaster researching the use of red blood cells to transport viral agents.
(Photo by Georgia Kirkos/McMaster University)
Physicists, chemists and immunologists at McMaster University have teamed up to modify red blood cells to transport viral agents which can safely trigger the immune system to protect the body against SARS-CoV-2, creating a promising new vehicle for vaccine delivery.
Developing new strategies and vaccine technologies is critical for controlling the pandemic and preparing for future outbreaks as the coronavirus continues to evolve and mutate, say the researchers.
The new method, described in the journal PLOS ONE is an entirely unique approach to vaccination. Red blood-cell membranes are embedded with SARS-CoV-2 spike proteins, which then form virus-like particles.
“We take red blood cells and remove everything from the inside. We then attach spike proteins to their outside to mimic a coronavirus,” explains graduate student Isabella Passos-Gastaldo, a lead author on the paper.
The particles, shown to activate the immune system and produce antibodies in mice, are completely harmless.
“Current vaccine delivery methods often cause drastic immune system reactions and have short-lived responses,” says Maikel Rheinstadter, a senior supervisor on the paper and a professor in the Department of Physics & Astronomy at McMaster.
“Some of the vaccines that have been developed have shown side effects. This delivery platform opens new possibilities for vaccines and therapeutics.”
The researchers found cells can be loaded with a large dose of viral proteins, yet likely produce few side effects, making the new method more tolerable and effective than other vaccine options.
“We have developed a method where we can trigger an immune response without the use of genetic material and yet we are able to synthesize these particles in a very short amount of time,” says Sebastian Himbert, lead author on the study and a recent graduate student in the Department of Physics & Astronomy at McMaster.
The technology can be quickly adapted to develop vaccines for variants or new viruses that may emerge in future.
“This is the kind of creative, interdisciplinary research that McMaster is known for. It was exhilarating working with physicists, structural biologists and immunologists to design a radically different vaccine platform,” says Dawn Bowdish, Professor of Medicine at McMaster and Canada Research Chair in Aging & Immunity and co-author of the paper.
The researchers first reported this technique in 2020, when they modified red blood cells to deliver drugs throughout the body, which could then target infections or treat catastrophic diseases such as cancer or Alzheimer’s.
“This platform makes our own blood cells smart in many different ways,” explains Rheinstadter. In this case it’s a vaccine.”
“We are using our own cells much like nano robots inside of our bodies and whenever they see a disease, they can fight it.”
Original Article: Researchers re-engineer red blood cells to trigger immune system against COVID-19
More from: McMaster University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Vaccine delivery method
- Vaccine Developers Leverage mRNA and Other Powerful Technologies
Variolation, an ancient method, involved the use of infectious material from ... for respiratory diseases by companies like Novavax. Innovation extends to vaccine delivery technology. One such ...
- A new coating method in mRNA engineering points the way to advanced therapies
Researchers have developed a novel method of adding polyethylene glycol molecules to engineered groups of messenger RNAs called 'mRNA polyplexes', which enable the cells that receive them to produce ...
- Microarray patches safe and effective for vaccinating children, trial suggests
The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the ...
- Cows' milk particles used for effective oral delivery of drugs
Researchers have found that tiny particles present in cows' milk could offer, for the first time, an effective method for the oral delivery of RNA drugs.
- Oral Vaccine Delivery: Can it Protect Against Non-mucosal Pathogens?
Numerous approaches have been or are being evaluated for optimal oral delivery ... indicate that oral vaccines could be an alternative immunization method for preventing malaria.
Go deeper with Google Headlines on:
Vaccine delivery method
[google_news title=”” keyword=”vaccine delivery method” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Modified red blood cells
- Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit ...
- 8 of the most expensive drugs in biopharma: Unraveling the costliest medications
Find out what the ten most expensive drugs in the world currently are, as several gene therapies top the list.
- Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show
The prodrug is also engineered to optimize transport through liver cells, aiming to achieve a radical cure with a single dose while minimizing the production of hemotoxic metabolites in the liver.
- New therapies in treatment of sickle cell anemia
modifying them in a lab to produce healthy red blood cells, and then reinfusing the modified stem cells back into the patient. Early results are promising, with some patients experiencing a ...
- FDA approves new sickle cell disease treatment
CRISPR modifies patients' blood stem cells. The modified stem cells then increase the production of the protein in red blood cells. Increasing the protein prevents red blood cells from becoming ...
Go deeper with Google Headlines on:
Modified red blood cells
[google_news title=”” keyword=”modified red blood cells” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]